Text Size

Lifeline-NET (Narrative Exposure Therapy): A Short-term Treatment for Traumatized Refugees and Asylum Seekers

This study is currently recruiting participants.
Verified October 2012 by University of Konstanz
Sponsor:
Information provided by (Responsible Party):
Martina Ruf, University of Konstanz
ClinicalTrials.gov Identifier:
NCT01720732
First received: August 7, 2012
Last updated: October 31, 2012
Last verified: October 2012
History of Changes
  Purpose

Evaluation of a short version of Narrative Exposure Therapy


Condition Intervention
Lifeline NET
Short Version of Narrative Exposure Therapy
Trauma Treatment
 Behavioral: Lifeline NET

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment

Resource links provided by NLM:

MedlinePlus related topics: Injuries Wounds
U.S. FDA Resources

Further study details as provided by University of Konstanz:

Primary Outcome Measures:
  • PTSD [ Time Frame: 9 months follow up ] [ Designated as safety issue: No ]
    Posttraumatic Stress Disorder Clinician Administered PTSD Scale


Secondary Outcome Measures:
  • Other Symptoms following and related to Trauma, e.g. Depression, Dissociation [ Time Frame: 9 months follow up ] [ Designated as safety issue: No ]
    Other Symptoms following and related to Trauma, e.g. Depression, Dissociation


Other Outcome Measures:
  • Social functioning, Life Satisfaction, Aggression [ Time Frame: 9 months follow up ] [ Designated as safety issue: No ]

Estimated Enrollment: 30
Study Start Date: October 2012
Estimated Study Completion Date: November 2014
Estimated Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Lifeline NET
Lifeline-NET (Short Version of NET)
 Behavioral: Lifeline NET
Short Version of Narrative Exposure Therapy
Other Names:
  • LL-NET
  • Lifeline NET
No Intervention: TAU
Treatment as Usual

  Eligibility

Ages Eligible for Study:   12 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • PTSD

Exclusion Criteria:

  • Psychotic Disorder,
  • Severe Substance Dependence
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01720732

Contacts
Contact: Martina E Ruf, PhD +49 7531 88 ext 4705 martina.ruf@uni-konstanz.de
Contact: Thomas R Elbert, Prof +49 7531 88 ext 4609 thomas.elbert@uni-konstanz.de

Locations
Germany
University of Konstanz Recruiting
Konstanz, Germany
Contact: Martina E Ruf, PhD         martina.ruf@uni-konstanz.de    
Contact: Thomas R Elbert, Prof         thomas.elbert@uni-konstanz.de    
Principal Investigator: Thomas R Elbert, Prof            
Principal Investigator: Martina E Ruf, PhD            
Principal Investigator: Veronika Mueller, MA            
Sponsors and Collaborators
University of Konstanz
  More Information

Additional Information:
NGO  This link exits the ClinicalTrials.gov site
Related Info  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: Martina Ruf, PhD, University of Konstanz
ClinicalTrials.gov Identifier: NCT01720732     History of Changes
Other Study ID Numbers: LL-NET2012
Study First Received: August 7, 2012
Last Updated: October 31, 2012
Health Authority: University of Konstanz: Germany

ClinicalTrials.gov processed this record on June 18, 2013